An adult case of chronic myelogenous leukemia with myeloblastic involvement of the central nervous system.
A 31-year-old female with chronic myelogenous leukemia, who developed myeloblastic involvement of the central nervous system during acute myeloblastic transformation of the disease, was treated with methotrexate intrathecally. The therapy produced prompt clinical response and complete reversal of abnormal cerebrospinal fluid findings. However, the patient expired 10 months following the acute blastic crisis.
D000328:Adult; D002177:Candidiasis / Q000150:complications; D002493:Central Nervous System Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D007951:Leukemia, Myeloid / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000209:etiology; D008577:Meningeal Neoplasms / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use
D008727:Methotrexate